Compugen (CGEN) Non-Current Assets (2009 - 2026)
Compugen (CGEN) reported Non-Current Assets of $8.6 million for Q1 2026, little changed on a YoY basis from $8.5 million in Q1 2025, and little changed sequentially from $8.5 million in Q4 2025.
Compugen (CGEN) Non-Current Assets (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Non-Current Assets data on file, last reported at $8.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets changed 0.32% year-over-year to $8.6 million; the trailing twelve-month figure through Mar 2026 stood at $8.6 million (changed 0.32% YoY), and the FY2025 full-year result was $8.5 million, down 5.0% from the prior year.
- Non-Current Assets was little changed at $8.6 million in Q1 2026, from $8.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $9.0 million in Q4 2024 to a low of $6.8 million in Q4 2023.
- A 5-year average of $8.3 million and a median of $8.3 million in 2022 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets declined 16.1% in 2023 and jumped 33.21% in 2024, its largest moves.
- Tracing CGEN's Non-Current Assets over 5 years: stood at $8.1 million in 2022, then decreased by 16.1% to $6.8 million in 2023, then jumped by 33.21% to $9.0 million in 2024, then fell by 5.0% to $8.5 million in 2025, then climbed by 0.34% to $8.6 million in 2026.
- Business Quant data shows CGEN's Non-Current Assets at $8.6 million in Q1 2026, $8.5 million in Q4 2025, and $8.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | 8.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.58 Mn |
| Dec 31, 2025 | 8.55 Mn |
| Sep 30, 2025 | 8.93 Mn |
| Jun 30, 2025 | 8.88 Mn |
| Mar 31, 2025 | 8.55 Mn |
| Dec 31, 2024 | 9.00 Mn |
| Sep 30, 2024 | 8.69 Mn |
| Jun 30, 2024 | 8.03 Mn |
| Mar 31, 2024 | 8.13 Mn |
| Dec 31, 2023 | 6.76 Mn |
| Sep 30, 2023 | 7.34 Mn |
| Jun 30, 2023 | 7.66 Mn |
| Mar 31, 2023 | 7.88 Mn |
| Dec 31, 2022 | 8.05 Mn |
| Sep 30, 2022 | 8.33 Mn |
| Jun 30, 2022 | 8.33 Mn |
| Mar 31, 2022 | 8.81 Mn |
| Dec 31, 2021 | 8.94 Mn |
| Sep 30, 2021 | 9.01 Mn |
| Jun 30, 2021 | 9.06 Mn |